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Abstract
Background: Molluscum contagiosum virus (MCV) causes an innocuous yet persistent skin infection in immunocompetent
individuals and is spread by contact with lesions. Studies point to atopic dermatitis (AD) as a risk factor for MCV infection;
however, there are no longitudinal studies that have evaluated this hypothesis.
Methods: Outpatient visit data from fiscal years 2001–2009 for American Indian and Alaska Native (AI/AN) children were
examined to describe the incidence of molluscum contagiosum (MC). We conducted a case-control study of patients ,5
years old at an Indian Health Service (IHS) clinic to evaluate dermatological risk factors for infection.
Results: The incidence rate for MC in children ,5 years old was highest in the West and East regions. MC cases were more
likely to have a prior or co-occurring diagnosis of eczema, eczema or dermatitis, impetigo, and scabies (p,0.05) compared
to controls; 51.4% of MC cases had a prior or co-occurring diagnosis of eczema or dermatitis.
Conclusions: The present study is the first demonstration of an association between AD and MC using a case-control study
design. It is unknown if the concurrent high incidence of eczema and MC is related, and this association deserves further
investigation.
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Introduction
Molluscum contagiosum (MC) is a skin disease caused by
molluscum contagiosum virus (MCV), a poxvirus. The infection
causes firm, small, papular lesions, often with an umbilicated
center. Lesions may have a region of erythema and can be found
anywhere on the body. Lesions may remain for many weeks to
months before resolving without treatment; however, in immuno-
compromised individuals, infection with MCV can cause giant
lesions and a large number of lesions that require treatment.
Diagnosis is usually made upon visual inspection of the lesions.
Although rarely pursued, laboratory confirmation is available.
There are several approaches to treating MC lesions, including
physical destruction (cryotherapy, curettage, laser therapy) or use
of immunomodulatory medicines (topical imiquimod) [1,2].
MCV is spread by contact with lesion material from an affected
individual. Recommendations to prevent the spread of MCV on
an individual’s body or to others may include keeping the lesions
covered and not sharing clothing, linens, or items that may contain
lesion exudate with others [3]. Also, avoiding any behavior that
would open the lesion and spread the material, such as shaving [4],
scratching, and electrolysis [5], is recommended to prevent spread
of the virus. An association between swimming pool use and MCV
infection has been reported [6,7], but robust scientific data do not
exist to firmly support this association. Although benign, MC can
have an adverse effect on patients’ and their families’ lives, causing
emotional concern and anxiety about physical manifestations of
the infection [8].
There have been notable clinical cases of patients who present
with atopic dermatitis (AD, including eczema) and have concur-
rent extensive MC lesions [9,10]. One clinical review of 284
children noted more lesions and a greater extent of surrounding
eczema in patients presenting with MC and AD compared to
those patients presenting with MC alone [11]. Indeed, there are
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indications that AD may be a risk factor for acquisition of MCV
and that patients with AD may suffer a more extensive course of
MC illness [12], but, to date, there are no case-control studies to
evaluate these hypotheses.
Although MCV infection occurs in individuals of all ages, the
infection is seen most often in children [13–15]. Publications often
associate MC with tropical environments, the developing world,
and poor living conditions, but infections are seen worldwide in a
multitude of climates [8,13,16,17]. An analysis of Indian Health
Service (IHS) outpatient visit data showed a higher incidence of
MC in American Indian/Alaska Native (AI/AN) children aged 1–
4 years old compared to other age groups, and this rate was
particularly high in the IHS West region [15]. This increased
incidence and disparity seen among IHS AI/AN patients,
specifically those in the West region, warranted further investiga-
tion of cases and their potential risk factors.
We present a study designed to determine potential dermato-
logical risk factors of MCV infection among AI/AN children seen
in IHS facilities with a high incidence of MC. Furthermore, we
investigated the occurrence of those risk factors in patients with
MC.
Materials and Methods
Incidence of MC at IHS outpatient facilities
The national Indian Health Service (IHS) direct and contract
care outpatient visit data for fiscal years 2001–2009 were obtained
from the IHS National Patient Information Reporting System
(NPIRS) [18]. These data consist of all outpatient visit records
from IHS-operated, tribally-operated and community hospitals
and facilities that are contracted with the IHS or with tribes to
provide healthcare services to eligible AI/AN persons [19]. The
IHS administrative areas were classified into regions as described
by the IHS: Alaska, East (Nashville), Northern Plains East
(Bemidji), Northern Plains West (Aberdeen and Billings), Southern
Plains (Oklahoma), Southwest (Albuquerque, Navajo, Phoenix,
and Tucson), and West (California and Portland). Outpatient visit
records were selected for AI/AN children ,5 years of age listing
the International Classification of Diseases, 9th Revision, Clinical
Modification (ICD-9-CM) code for MC (078.0) [20].
The outpatient visit records for AI/AN children ,5 years of age
with a MC diagnosis were examined by sex, age group (,1 and 1–
4 years) and IHS region. The IHS West region, a region with a
high incidence of MC [15], was further analyzed by Service Unit
to identify those Service Units with the highest MC incidence.
Annual and average annual MC-associated incidence rates per
10,000 children ,5 years of age from the corresponding group
were calculated for the study period using the annual number of
patients with a MC diagnosis and the corresponding annual fiscal
year IHS user population as the denominator. The IHS user
population includes all registered AI/AN persons who have
received IHS-funded health care services at least once during the
preceding three years [19].
Case-control study
A case-control study was conducted to identify clinical
characteristics of dermatological conditions among children ,5
years of age that may be associated with the occurrence of MC
using chart review at Facility B. Facility B is contained within
Service Unit B, a service unit with a high annual incidence of MC
in children ,5 years of age (Table 1). The MC outpatient cases
were identified as described below. Controls were randomly
selected as children ,5 years of age with outpatient visits during
the same time period as cases, and did not list a current or prior
MC diagnosis. Complete medical charts were abstracted for 84
cases and 109 controls at Facility B. Data from MC case patients
were abstracted if the specific diagnosis of MC was listed on the
medical chart. The specific dermatological conditions abstracted
from medical charts included candidiasis; dermatitis; dry skin;
eczema; hand, foot, and mouth disease; impetigo; rash; ringworm;
scabies; varicella; viral exanthem; and viral warts. The diagnoses
for additional conditions were captured as either co-occurring with
the MC diagnosis and/or occurring prior to the MC diagnosis. A
univariate analysis was conducted to identify clinical characteris-
tics associated with MC. We refer to these significant character-
istics as ‘risk factors’ noting that this analysis does not identify
causation, but rather an association of a characteristic with MC.
Characteristics of MC cases at two outpatient clinics
Two IHS facilities (Facilities A and B) in the northwest United
States were identified from IHS Service Units A and B,
respectively, with a high incidence of MC among AI/AN children
,5 years of age (Table 1). A chart review of records was
conducted for all MC-associated outpatients ,5 years of age
during fiscal years 2001–2009 at the two facilities. A data
collection form was developed to extract demographic and clinical
information from medical records for these patients.
The ICD-9-CM code diagnosis of MC was validated by a
healthcare provider’s noted diagnosis entered on the medical
record, and patients meeting these criteria were considered MC
cases. Data were abstracted from a total of 175 cases (97.2% of
identified ICD-9-CM diagnoses) from Facility A and 84 cases
(81.6% of identified ICD-9-CM diagnoses) from Facility B. Data
were not abstracted from all of the ICD-9-CM diagnosed cases
because of missing medical records (n = 24, 8.5%) or misdiagnoses
(n = 8, 2.8%). Age in months at first visit was compared using the
Wilcoxon rank-sum test [21]. Statistical significance was consid-
ered at the p,0.05 level for all analyses.
Ethics Statement
The chart review at the two health facilities was determined to
be public health non-research by CDC and exempt from review
by the Portland Area IHS Human Subjects Institutional Review
Board. Patient data was de-identified and anonymized prior to
analysis.
Results
Incidence of MC at IHS outpatient facilities nationwide
The incidence of MC infections was calculated from IHS
outpatient visit records for AI/AN children ,5 years of age
(Table 1). The overall incidence rate was 68.5 per 10,000 children,
and the rate was similar amongst males and females. Children
aged 1–4 years had an incidence rate four times higher than the
rate for children ,1 year old. The incidence rate was highest in
the West (132.9) and East (121.5) IHS regions. Service Units A and
B (including corresponding Facilities A and B) had particularly
high incidence rates of 188.4 and 222.8, respectively. At Service
Unit B, the incidence rate for children aged 1–4 years old was
eight times that of children ,1 year old.
Dermatological risk factors for MCV infection
Patient charts were reviewed from 175 cases (67.6%) at Facility
A and 84 cases (32.4%) at Facility B. There were slightly more
female (52.1%) than male patients (47.9%) (Table 2). The average
age of patients at their first diagnosis of MC was 35 months with a
median of 36 months. Approximately 95% of MC patients were
one year of age or older (Table 2).
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Data were collected for each visit where MC was diagnosed,
including multiple visits. The majority of cases (68.7%) had only
one diagnosis of MC. However, a substantial proportion of
patients had multiple diagnoses over time: 19% of patients had a
MC diagnosis for two visits, 9.7% for three visits, 1.9% for four
visits, and 0.8% (2 patients) for five visits. Common descriptions
for lesion presentation included characteristic ‘pitted’ or ‘umbil-
icated’ lesions (49.3%), ‘colorless’ (44.8%), ‘red’ or ‘pink’ (17.2%),
erythema (16.4%), and pruritus (25.4%).
A case-control study to evaluate potential dermatological risk
factors for MCV infection was conducted using medical records
obtained at Facility B. The gender distribution was similar among
MC cases and controls, and controls were significantly younger
than case patients (p,0.0001, Table 2). Control patients present-
ed to the clinic with a variety of chief complaints, whereas the chief
compliant for most of the visits for case patients was self-described
bumps or rash (84.3%).
Dermatological conditions were examined as potential risk
factors for MCV infection at three different time periods relative to
the visit - a) prior dermatological conditions, b) co-occurring
dermatological conditions, and c) a combination of prior and co-
occurring conditions. Considering prior dermatological conditions
only, cases were more likely to have had a prior diagnosis of
eczema (OR = 2.51, 95% CI 1.10–6.01), eczema or dermatitis
(OR = 2.09, 95% CI 1.16–3.81), impetigo (OR = 2.88, 95% CI
1.40–6.10), or scabies (OR = 3.72, 95% CI 1.04–17.40) compared
to controls (p,0.05) (Table 3). Considering co-occurring condi-
tions only, cases were more likely to have diagnoses of eczema
(OR = 5.71, 95% CI 1.98–20.66), eczema or dermatitis
(OR = 2.97, 95% CI 1.24–7.69), or impetigo (OR = 4.86, 95%
CI 1.14–33.24) than controls (p,0.05) (Table S1 in File S1).
Grouping past and co-occurring conditions together, eczema
(OR = 3.58, 95% CI 1.77–7.52), eczema or dermatitis (OR = 2.28,
95% CI 1.28–4.11), impetigo (OR = 3.40, 95% CI 1.73–6.92), and
scabies (OR = 3.72, 95% CI 1.04–17.40) were more likely to occur
in MC cases compared to controls (p,0.05) (Table S2 in File S1).
The frequencies of these risk factors in MC patients at both
facilities and for the three time periods examined are shown in
Figure 1. In considering any time period, 30.9% of MC cases had
a diagnosis of eczema and 51.4% had a diagnosis of eczema or
dermatitis. Also, 26.6% and 8.1% of MC cases had a diagnosis of
impetigo or scabies, respectively.
Table 1. Incidence ratesa of molluscum contagiosum in American Indian children ,5 years of age, fiscal years 2001–2009.
Overall Sex Age (years)
Male Female ,1 1–4
Service Unit A 188.4 179.2 198.7 45.1 212.7
Service Unit B 222.8 198.5 247.7 31.9 265.3
IHS Overall 68.5 67.4 69.6 19.2 77.6
Region
Alaska 83.2 77.7 89.1 24.4 96.6
East 121.5 132.5 119.4 40.5 135.3
Northern Plains East 77.8 75.0 80.7 19.4 87.1
Northern Plains West 71.4 67.0 75.8 19.9 81.0
Southern Plains 51.1 53.2 48.9 16.5 56.7
Southwest 48.3 48.4 48.2 13.3 55.2
West 132.9 129.6 136.4 35.1 148.2
aIncidence rates are reported as per 10,000 children ,5 years of age.
doi:10.1371/journal.pone.0103419.t001
Table 2. Demographic characteristics of American Indian molluscum contagiosum case and control patients ,5 years old by
facility.
Facility A Facility B
Casesa Casesa Controlsa
Total 175 (100) 84 (100) 109 (100)
Sex
Male 87 (50) 37 (44) 50 (46)
Female 88 (50) 47 (56) 59 (54)
Age (years)
,1 9 (5) 5 (6) 40 (37)
1–4 166 (95) 79 (94) 69 (63)
aNumber of patients (%).
doi:10.1371/journal.pone.0103419.t002
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Discussion
Published data show a higher incidence of MC in AI/AN
children ,5 years of age, specifically amongst children aged 1–4
years [15]; and the more recent measures here show the same
trend across IHS regions, with the West region having the highest
incidence. Moreover, this age distribution has been noted
previously in children ,5 years old [13,22–24]. Some authors
have hypothesized that children in this age range have behaviors
and activities that facilitate close contact with affected individuals,
Table 3. Univariate analysis of prior dermatological conditions for American Indian molluscum contagiosum (MC) cases and
control patients ,5 years of age at facility B.a
Condition Case N (%) Control N (%) OR (95% CI) p-value
Eczema
No 67 (79.8) 99 (90.8) Reference
Yes 17 (20.2) 10 (9.2) 2.51 (1.10–6.01) 0.029
Eczema or Dermatitisb
No 44 (52.4) 76 (69.7) Reference
Yes 40 (47.6) 33 (30.3) 2.09 (1.16–3.81) 0.014
Impetigo
No 59 (70.2) 95 (87.2) Reference
Yes 25 (29.8) 14 (12.8) 2.88 (1.40–6.10) 0.004
Scabies
No 76 (90.5) 106 (97.2) Reference
Yes 8 (9.5) 3 (2.8) 3.72 (1.04–17.40) 0.043
aSignificant variables (conditions) are shown here. Non-significant variables were candidiasis; dermatitis; dry skin; hand, foot, and mouth disease; rash; ringworm;
varicella; viral exanthem; and viral warts.bThis variable includes diagnoses of eczema or dermatitis.
doi:10.1371/journal.pone.0103419.t003
Figure 1. The frequency of dermatological risk factors in MC case patients at three time periods relative to the initial visit where MC
was diagnosed - a) prior dermatological conditions (blue), b) co-occurring dermatological conditions (red), and c) a combination of
prior and co-occurring conditions (green). MC cases include those from Facilities A and B.
doi:10.1371/journal.pone.0103419.g001
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thereby facilitating the spread of MCV to others [23,25], and
others have suggested that maternal antibodies may protect
newborn infants from infection [23]. Cases from the two IHS
facilities examined in the present study had a slight predominance
of female patients versus male. There are no consistent data in the
literature to suggest one gender is overrepresented by MCV
infections [8].
The majority of MC cases in the present study were noted to
have a MC diagnosis only once, but over 30% of cases had MC on
multiple healthcare center visit records. The duration of illness
lasted for several months for many patients and up to one year for
one patient. MC is known to persist for months to years, eventually
resolving without treatment for many patients [3].
In this population of pediatric AI/AN patients with a high
burden of MC, there was an association between MC and prior or
co-occurring diagnosis of eczema, eczema or dermatitis, impetigo,
and scabies. Prior research has suggested a purported association
between patients with AD or eczema and MC [25–27], but this
study is the first to quantify this relationship. AD patients are
known to have an increased susceptibility to many dermatologic
infections and are at risk for severe complications from poxviral
infections, notably Orthopoxviruses including vaccinia virus
[22,28,29]. A study that utilized parent recall of prior dermato-
logical conditions in pediatric patients did not find an association
between MC illness and prior history of AD [30], but this
approach has the limitation of dependence on recall of clinical
diagnosis. Here, we utilized documented clinical diagnoses of MC
and concurrent or prior diagnosis of several dermatological skin
conditions. All of the significant conditions (eczema, eczema or
AD, impetigo, scabies) can compromise the integrity of the
external epidermal surface, providing portals of entry for the
establishment of viral infections. Eczema and AD can also be
considered manifestations of immune deficits or disregulation, and
this may yield a propensity to develop infections [22].
A recent study of pediatric health survey data suggested that
approximately 10% of all children ,17 years old in the United
States have had a prior diagnosis of eczema, and children ,4
years old have the highest incidence of eczema. Also, the incidence
of eczema differed geographically, with the western United States
having a notably high incidence (although, high incidence rates
were is not observed exclusively in the western United States) [31].
Over half of the pediatric MC patients in the present study had a
diagnosis of eczema or dermatitis, a remarkably high frequency of
diagnoses compared to national data. In a published chart review
by Berger, et al., a high percentage of pediatric MC patients
(37.2%) had a history of AD [28]. It is unknown if the co-occurring
high incidence of eczema and MC are related.
The present study has several possible limitations, as well as,
some unique attributes that contribute to the strength of our
conclusions. Because the AI/AN populations studied are relatively
isolated, the IHS clinic, which offers no-cost health care to eligible
beneficiaries, is the source of the vast majority of health care for
these populations. It is believed that the charts at Facilities A and B
represented most of the clinical visits for an individual over their
life to date (up to 5 years of age), so our ascertainment of prior
dermatological conditions was likely to be complete. Also, this
study was able to capture and review the majority of MC cases ,5
years of age at the two outpatient clinics. However, clinical
diagnoses (including those for impetigo and scabies) were based on
clinical examination alone and never laboratory confirmed, which
likely suggests that some diagnoses may have been inaccurate.
Diagnostic laboratory testing was only requested for one MC case
and the results were not listed in the chart. Similarly, in most
diagnoses of AD there was no documentation of any additional
laboratory evaluation or referral to a dermatologist for evaluation.
Further, surrounding erythema is known to occur with some MC
lesions and this was noted for 16.4% of MC cases reviewed here. It
is unknown if the presence of erythema surrounding lesions was
considered by the practitioners to be a presentation of MC or a
presentation of atopy. Such possible misdiagnoses could lead to a
misclassification bias in our study, although unless primary care
providers systematically misdiagnosed MC for AD, there should
not be a significant effect on our measures of association. Further,
descriptive information was missing from some charts, particularly
information relevant to the MC presentation.
The AI/AN population harbors a high burden of infectious
diseases [32,33], and MC in the pediatric population is no
exception. The present study affirms the association between AD
and MC; however, the mechanisms of such an association are
unknown and deserve further attention and study in additional
patient populations. AI/AN pediatric populations would benefit
from targeted outreach to prevent and mitigate the spread of
MCV among children.
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